Linda Marsh serves as Executive at Fulgent Genetics, Inc., where they oversee executive responsibilities. Since joining the company, Linda Marsh has executed 14 insider transactions totaling $9.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 3, 2025 involved exercising options for 20,000 shares valued at $364.0K.
Linda Marsh currently holds 103,641 shares of Fulgent Genetics, Inc. (FLGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Linda Marsh has been a net seller of FLGT stock. They have purchased $0 and sold $9.3M worth of shares.
Linda Marsh's most recent insider trade was on Nov 3, 2025, when they sold 20,000 shares at $18.20 per share.
Get notified when new Form 4 filings are submitted
| 11,033 |
| $32.99 |
| Discretionary |
| Sep 10, 2024 | ASTH | $168.8K | Option Exercise | 11,000 | $15.35 | Discretionary |
| Sep 10, 2024 | ASTH | $168.8K | Payment | 3,522 | $47.93 | Discretionary |
| Aug 13, 2024 | ASTH | $0 | Award | 3,564 | $N/A | Discretionary |
| May 16, 2024 | FLGT | $0 | Award | 8,000 | $N/A | Discretionary |
| Dec 15, 2023 | AMEH | $0 | Award | 3,650 | $N/A | Discretionary |
| May 18, 2023 | FLGT | $0 | Award | 5,059 | $N/A | Discretionary |
| Mar 14, 2023 | AMEH | $9.5M | Disposition | 270,081 | $35.32 | Discretionary |
| Mar 9, 2023 | AMEH | $625.0K | Option Exercise | 62,500 | $10.00 | Discretionary |
| Aug 1, 2022 | FLGT | $0 | Award | 1,600 | $N/A | Discretionary |
| Jun 17, 2022 | AMEH | $9.3M | Sale | 250,000 | $37.00 | Discretionary |
| May 18, 2022 | FLGT | $0 | Award | 2,000 | $N/A | Discretionary |
| May 20, 2021 | FLGT | $0 | Award | 2,000 | $N/A | Discretionary |